MEDPLUS
Diupdate
MEDPLUS looks good --- Weekly Close above 735 then chances of 950 to 1250, with a strong support of 630.
Just Sharing to build my confidence. No suggestion of buying stock.
Just Sharing to build my confidence. No suggestion of buying stock.
Catatan
Overview: MedPlus Health Services Limited operates in India as a retailer of medicines and general items, with a market cap of ₹76.36 billion.
Operations: The company's revenue primarily comes from its retail segment, which generated ₹57.43 billion, complemented by its diagnostics segment with ₹852.29 million.
Insider Ownership: 13.5%
Earnings Growth Forecast: 41.8% p.a.
MedPlus Health Services is poised for significant earnings growth at 41.8% annually, surpassing the Indian market's average. Despite this, its return on equity is forecasted to remain low at 11%. Revenue growth of 16.7% also exceeds market expectations but remains below a high-growth threshold. Recent regulatory challenges could impact operations slightly, with potential revenue losses totaling INR 1.334 million from temporary store suspensions in Maharashtra and Andhra Pradesh.
Trade aktif
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.